LCN2 serum levels play an important role in the diagnosis of endometrial cancer (31), and upregulation of LCN2 expression promotes drug resistance in endometrial cancer cells and inhibits the ferroptosis process (32). This evidence concerns the gene LCN2 and endometrial cancer.